Biogen Idec Shares Up 22.3% Since SmarTrend's Buy Recommendation (BIIB)
September 13, 2016 at 02:02 AM EDT
SmarTrend identified an Uptrend for Biogen Idec (NASDAQ:BIIB) on July 7th, 2016 at $247.44. In approximately 2 months, Biogen Idec has returned 22.32% as of today's recent price of...